<DOC>
	<DOC>NCT01867047</DOC>
	<brief_summary>The purpose of this study is to determine the effects of Angiotension Converting Enzyme Inhibitors (ACE-I) during surgery and in the immediate postoperative period for patients undergoing elective total hip or knee arthroplasty.</brief_summary>
	<brief_title>ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>Patients electing to undergo primary or revision total hip or knee arthroplasty Currently taking an ACEI Trauma patients Immunosuppressed patients (HIV/AIDS, organ transplant recipients, chemotherapy patients, chronic steroid use) Patients with history of severe hypertension related illness such as hypertension associated with stroke or myocardial infarction Patients in who continuation of their ACEI is expressly mandated by their prescribing physician</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>